D-0018-2027 Class II Ongoing
FDA drug recall D-0018-2027 was initiated by Carolina Infusion, LLC on Sep 10, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. The recall status is ongoing. Affected quantity: 8 x 0.1 ml syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 14, 2026
- Initiation Date
- Sep 10, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 x 0.1 ml syringes
Product description
SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Reason for recall
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Distribution pattern
Nationwide within the U.S
Code information
Lot: 08262026@6, BUD:10/10/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0018-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026